Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Research

Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures

Authors: Jieun Choi, Hyun Jin Min, Jeon-Soo Shin

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

Objective

Febrile seizures are the most common form of childhood seizures. Fever is induced by pro-inflammatory cytokines during infection, and pro-inflammatory cytokines may trigger the development of febrile seizures. In order to determine whether active inflammation, including high mobility group box-1 (HMGB1) and pro-inflammatory cytokines, occurs in children with febrile seizures or epilepsy, we analyzed cytokine profiles of patients with febrile seizures or epilepsy.

Methods

Forty-one febrile seizure patients who visited the emergency department of Seoul National University Boramae Hospital from June 2008 to May 2009 were included in this study. Blood was obtained from the febrile seizure child patients within 30 minutes of the time of the seizure; subsequently, serum cytokine assays were performed. Control samples were collected from children with febrile illness without convulsion (N = 41) and similarly analyzed. Serum samples from afebrile status epilepticus attacks in intractable epilepsy children (N = 12), afebrile seizure attacks in generalized epilepsy with febrile seizure plus (GEFSP) children (N = 6), and afebrile non-epileptic controls (N = 7) were also analyzed.

Results

Serum HMGB1 and IL-1β levels were significantly higher in febrile seizure patients than in fever only controls (p < 0.05). Serum IL-6 levels were significantly higher in typical febrile seizures than in fever only controls (p < 0.05). Serum IL-1β levels were significantly higher in status epilepticus attacks in intractable epilepsy patients than in fever only controls (p < 0.05). Serum levels of IL-1β were significantly correlated with levels of HMGB1, IL-6, and TNF-α (p < 0.05).

Conclusions

HMGB1 and pro-inflammatory cytokines were significantly higher in febrile seizure children. Although it is not possible to infer causality from descriptive human studies, our data suggest that HMGB1 and the cytokine network may contribute to the generation of febrile seizures in children. There may be a potential role for anti-inflammatory therapy targeting cytokines and HMGB1 in preventing or limiting febrile seizures or subsequent epileptogenesis in the vulnerable, developing nervous system of children.
Appendix
Available only for authorised users
Literature
1.
Hauser WA: The prevalence and incidence of convulsive disorders in children. Epilepsia. 1994, 35 (Suppl 2): S1-6.CrossRefPubMed
2.
Millichap JG: Studies in febrile seizures. I. Height of body temperature as a measure of the febrile-seizure threshold. Pediatrics. 1959, 23: 76-85.PubMed
3.
Virta M, Hurme M, Helminen M: Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr Neurol. 2002, 26: 192-195. 10.1016/S0887-8994(01)00380-0.CrossRefPubMed
4.
Kanemoto K, Kawasaki J, Yuasa S, Kumaki T, Tomohiro O, Kaji R, Nishimura M: Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia. 2003, 44: 796-799. 10.1046/j.1528-1157.2003.43302.x.CrossRefPubMed
5.
Tilgen N, Pfeiffer H, Cobilanschi J, Rau B, Horvath S, Elger CE, Propping P, Heils A: Association analysis between the human interleukin 1beta (-511) gene polymorphism and susceptibility to febrile convulsions. Neurosci Lett. 2002, 334: 68-70. 10.1016/S0304-3940(02)01069-8.CrossRefPubMed
6.
Chou IC, Lin WD, Wang CH, Tsai CH, Li TC, Tsai FJ: Interleukin (IL)-1beta, IL-1 receptor antagonist, IL-6, IL-8, IL-10, and tumor necrosis factor alpha gene polymorphisms in patients with febrile seizures. Journal of clinical laboratory analysis. 2010, 24: 154-159. 10.1002/jcla.20374.CrossRefPubMed
7.
Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG: Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994, 331: 432-438. 10.1056/NEJM199408183310703.CrossRefPubMed
8.
Chiu SS, Tse CY, Lau YL, Peiris M: Influenza A infection is an important cause of febrile seizures. Pediatrics. 2001, 108: E63-10.1542/peds.108.4.e63.CrossRefPubMed
9.
Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ: Interleukin-1beta contributes to the generation of experimental febrile seizures. Annals of neurology. 2005, 57: 152-155. 10.1002/ana.20358.PubMedCentralCrossRefPubMed
10.
Wang S, Cheng Q, Malik S, Yang J: Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther. 2000, 292: 497-504.PubMed
11.
Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG: Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999, 19: 5054-5065.PubMed
12.
Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS: High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF-{alpha} Production in Human Monocytes. J Immunol. 2008, 180: 5067-5074.CrossRefPubMed
13.
Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE, Shin JS: HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol. 2009, 182: 5800-5809. 10.4049/jimmunol.0801873.CrossRefPubMed
14.
Rauvala H, Rouhiainen A: Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta. 2010, 1799: 164-170.CrossRefPubMed
15.
Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, et al: Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010, 16: 413-419. 10.1038/nm.2127.CrossRefPubMed
16.
17.
Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I: High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem. 2003, 49: 1535-1537. 10.1373/49.9.1535.CrossRefPubMed
18.
Muller S, Ronfani L, Bianchi ME: Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med. 2004, 255: 332-343. 10.1111/j.1365-2796.2003.01296.x.CrossRefPubMed
19.
Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999, 285: 248-251. 10.1126/science.285.5425.248.CrossRefPubMed
20.
Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002, 418: 191-195. 10.1038/nature00858.CrossRefPubMed
21.
van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, Tanck MW, Dugernier T, Ishizaka A, Boermeester MA, van der Poll T: Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med. 2007, 35: 2799-2804. 10.1097/01.CCM.0000287588.69000.97.CrossRefPubMed
22.
Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, et al: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003, 48: 971-981. 10.1002/art.10859.CrossRefPubMed
23.
Ombrellino M, Wang H, Ajemian MS, Talhouk A, Scher LA, Friedman SG, Tracey KJ: Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet. 1999, 354: 1446-1447. 10.1016/S0140-6736(99)02658-6.CrossRefPubMed
24.
Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, et al: Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock (Augusta, Ga). 2006, 25: 571-574. 10.1097/01.shk.0000209540.99176.72.CrossRef
25.
Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, et al: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004, 170: 1310-1316. 10.1164/rccm.200402-188OC.CrossRefPubMed
26.
Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y: Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 2006, 33: 359-363. 10.1097/01.mpa.0000236741.15477.8b.CrossRefPubMed
27.
Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A: A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain. 2008, 131: 3256-3265. 10.1093/brain/awn271.PubMedCentralCrossRefPubMed
28.
Bezzi P, Volterra A: A neuron-glia signalling network in the active brain. Current opinion in neurobiology. 2001, 11: 387-394. 10.1016/S0959-4388(00)00223-3.CrossRefPubMed
29.
Aronica E, Gorter JA, Redeker S, Ramkema M, Spliet WG, van Rijen PC, Leenstra S, Troost D: Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol. 2005, 31: 280-291. 10.1111/j.1365-2990.2004.00636.x.CrossRefPubMed
30.
Choi J, Nordli DR, Alden TD, DiPatri A, Laux L, Kelley K, Rosenow J, Schuele SU, Rajaram V, Koh S: Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation. 2009, 6: 38-10.1186/1742-2094-6-38.PubMedCentralCrossRefPubMed
31.
Rosenbaum KJ, Sapthavichaikul S, Skovsted P: Sympathetic nervous system response to lidocaine induced seizures in cats. Acta Anaesthesiol Scand. 1978, 22: 548-555. 10.1111/j.1399-6576.1978.tb01337.x.CrossRefPubMed
32.
Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L, Stewart M: Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia. 2008, 49: 982-996. 10.1111/j.1528-1167.2008.01545.x.CrossRefPubMed
33.
Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005, 6: 775-786.CrossRefPubMed
34.
Dube CM, Ravizza T, Hamamura M, Zha Q, Keebaugh A, Fok K, Andres AL, Nalcioglu O, Obenaus A, Vezzani A, Baram TZ: Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci. 2010, 30: 7484-7494. 10.1523/JNEUROSCI.0551-10.2010.PubMedCentralCrossRefPubMed
35.
Lahat E, Livne M, Barr J, Katz Y: Interleukin-1beta levels in serum and cerebrospinal fluid of children with febrile seizures. Pediatr Neurol. 1997, 17: 34-36. 10.1016/S0887-8994(97)00034-9.CrossRefPubMed
36.
Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, Kelley KW: Molecular basis of sickness behavior. Ann N Y Acad Sci. 1998, 856: 132-138. 10.1111/j.1749-6632.1998.tb08321.x.CrossRefPubMed
37.
Dinarello CA: Biologic basis for interleukin-1 in disease. Blood. 1996, 87: 2095-2147.PubMed
38.
Dinarello CA: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004, 10: 201-222.PubMed
39.
van Dam AM, Poole S, Schultzberg M, Zavala F, Tilders FJ: Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann N Y Acad Sci. 1998, 840: 128-138. 10.1111/j.1749-6632.1998.tb09557.x.CrossRefPubMed
40.
Eriksson C, Tehranian R, Iverfeldt K, Winblad B, Schultzberg M: Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J Neurosci Res. 2000, 60: 266-279. 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P.CrossRefPubMed
41.
Rooker S, Jander S, Van Reempts J, Stoll G, Jorens PG, Borgers M, Verlooy J: Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat. Mediators Inflamm. 2006, 2006: 90123.PubMedCentralCrossRefPubMed
42.
Tutuncuoglu S, Kutukculer N, Kepe L, Coker C, Berdeli A, Tekgul H: Proinflammatory cytokines, prostaglandins and zinc in febrile convulsions. Pediatr Int. 2001, 43: 235-239. 10.1046/j.1442-200x.2001.01389.x.CrossRefPubMed
43.
Haspolat S, Mihci E, Coskun M, Gumuslu S, Ozben T, Yegin O: Interleukin-1beta, tumor necrosis factor-alpha, and nitrite levels in febrile seizures. J Child Neurol. 2002, 17: 749-751. 10.1177/08830738020170101501.CrossRefPubMed
44.
De Sarro G, Russo E, Ferreri G, Giuseppe B, Flocco MA, Di Paola ED, De Sarro A: Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacology, biochemistry, and behavior. 2004, 77: 761-766. 10.1016/j.pbb.2004.01.012.CrossRefPubMed
45.
Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL: Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res. 2003, 73: 176-187. 10.1002/jnr.10635.CrossRefPubMed
46.
Furukawa K, Mattson MP: The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem. 1998, 70: 1876-1886.CrossRefPubMed
47.
Kalueff AV, Lehtimaki KA, Ylinen A, Honkaniemi J, Peltola J: Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci Lett. 2004, 365: 106-110. 10.1016/j.neulet.2004.04.061.CrossRefPubMed
48.
Masuyama T, Matsuo M, Ichimaru T, Ishii K, Tsuchiya K, Hamasaki Y: Possible contribution of interferon-alpha to febrile seizures in influenza. Pediatr Neurol. 2002, 27: 289-292. 10.1016/S0887-8994(02)00452-6.CrossRefPubMed
49.
Williams K, Dooley N, Ulvestad E, Becher B, Antel JP: IL-10 production by adult human derived microglial cells. Neurochem Int. 1996, 29: 55-64. 10.1016/0197-0186(95)00138-7.CrossRefPubMed
50.
Straussberg R, Amir J, Harel L, Punsky I, Bessler H: Pro- and anti-inflammatory cytokines in children with febrile convulsions. Pediatr Neurol. 2001, 24: 49-53. 10.1016/S0887-8994(00)00234-4.CrossRefPubMed
51.
Ishizaki Y, Kira R, Fukuda M, Torisu H, Sakai Y, Sanefuji M, Yukaya N, Hara T: Interleukin-10 is associated with resistance to febrile seizures: genetic association and experimental animal studies. Epilepsia. 2009, 50: 761-767. 10.1111/j.1528-1167.2008.01861.x.CrossRefPubMed
52.
Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP: Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab. 1998, 18: 1283-1287.CrossRefPubMed
53.
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 1996, 2: 788-794. 10.1038/nm0796-788.CrossRefPubMed
54.
Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG, Vezzani A: Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol. 2005, 57: 804-812. 10.1002/ana.20480.CrossRefPubMed
55.
Akassoglou K, Probert L, Kontogeorgos G, Kollias G: Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol. 1997, 158: 438-445.PubMed
56.
Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ: Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem. 2009, 109: 1237-1249. 10.1111/j.1471-4159.2009.06038.x.PubMedCentralCrossRefPubMed
57.
Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC: Control of synaptic strength by glial TNFalpha. Science. 2002, 295: 2282-2285. 10.1126/science.1067859.CrossRefPubMed
58.
Stellwagen D, Beattie EC, Seo JY, Malenka RC: Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci. 2005, 25: 3219-3228. 10.1523/JNEUROSCI.4486-04.2005.CrossRefPubMed
Metadata
Title
Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures
Authors
Jieun Choi
Hyun Jin Min
Jeon-Soo Shin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-135

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue

Review

Toll-like receptors in cerebral ischemic inflammatory injury

Research

Strain-dependent variation in the early transcriptional response to CNS injury using a cortical explant system

Research

Increased circulating leukocyte numbers and altered macrophage phenotype correlate with the altered immune response to brain injury in metallothionein (MT) -I/II null mutant mice

Research

Microglia use multiple mechanisms to mediate interactions with vitronectin; non-essential roles for the highly-expressed αvβ3 and αvβ5 integrins

Research

Neuroprotective response after photodynamic therapy: Role of vascular endothelial growth factor

Hypothesis

Neuro-inflammation, blood-brain barrier, seizures and autism